Targeted Toxin Therapy for Malignant Astrocytoma
- 1 March 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 46 (3) , 544-552
- https://doi.org/10.1097/00006123-200003000-00003
Abstract
THE POOR PROGNOSIS associated with malignant astrocytoma has led investigators to seek new, innovative methods of treatment. Targeted toxins represenKeywords
This publication has 20 references indexed in Scilit:
- In Vitro and In Vivo Variation in Transferrin Receptor Expression on a Human Medulloblastoma Cell LineNeurosurgery, 1995
- Human neurological cancer cells express interleukin‐4 (IL‐4) receptors which are targets for the toxic effects of IL4‐pseudomonas exotoxin chimeric proteinInternational Journal of Cancer, 1994
- Nude rat models for human tumor metastasis to CNSJournal of Neuro-Oncology, 1994
- Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cellsJournal of Neurosurgery, 1993
- In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiformeJournal of Neurosurgery, 1992
- Immunotoxins and central nervous system neoplasiaJournal of Neurosurgery, 1992
- Diphtheria toxin effects on brain-tumor xenograftsJournal of Neurosurgery, 1990
- Efficacy of intrathecal immunotoxin therapy in an animal model of leptomeningeal neoplasiaJournal of Neurosurgery, 1988
- Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxinJournal of Neurosurgery, 1987
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985